Jordan TurnbullCo-Founder, Co-CEO, CSO at Fuse VectorsSpeaker
Profile
Jordan Turnbull is the scientific co-founder and co-CEO of Fuse Vectors, advancing a cell-free AAV platform that enables rapid, high-quality vector production for next-generation gene therapies. He has led innovation strategies at leading biotech and pharmaceutical organizations, including ViraTherapeutics (Boehringer Ingelheim), Novo Nordisk, and ImmuneBridge, and earned his PhD in Biochemical Engineering from University College London, specializing in scalable viral vector purification and analysis. Jordan’s expertise spans vector characterization, process development, and analytical innovation, with a focus on translating cutting-edge science into scalable manufacturing solutions.
Agenda Sessions
Merck's EMEA Advance Biotech Grant at BIO-Europe
, 16:00View Session
